Market Research - Acceptability Study for a Range of MCT Products

Launched by DR. SCHÄR AG / SPA · Mar 12, 2020

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosis of epilepsy or a fatty acid oxidation disorder requiring a ketogenic or a specialist diet as part of their treatment, which includes MCT.
• • Subjects who are new to or already taking an MCT oil and are willing to try each of the 3 study products for 7 days each. 21 days taking product with 2 days between new product trialled.
• • Patients aged 3 years of age to adulthood.
• • Written informed consent obtained from patient or parental caregiver.
• Exclusion Criteria:
• • Presence of serious concurrent illness
• • Investigator's uncertainty about the willingness or ability of the patient to comply with the protocol requirements
• • Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study.
• • Any patients having taken antibiotics over the previous 2 weeks leading up to the study.
• • Patients less than 3 years of age.